Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada

Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada

Background: There are limited published data in the Canadian healthcare system on the use of granulocyte colony-stimulating factor (G-CSF) among patients with breast cancer. This study characterized real-world G-CSF use during the period surrounding the introduction of filgrastim biosimilar. Methods...

Full description

Bibliographic Details
Main Authors: Philip Q. Ding, Brandt J. Newcomer, Winson Y. Cheung
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
breast cancer
G-CSF
chemotherapy
biosimilar
trends
Canada
Online Access:https://www.mdpi.com/2072-6694/14/24/6197

Internet

https://www.mdpi.com/2072-6694/14/24/6197

Similar Items